Benzinga | Nov 5, 2020 07:19AM EST

Antares Pharma Q3 EPS $0.03 Beats $0.02 Estimate, Sales $40.00M Beat $35.67M Estimate

Antares Pharma (NASDAQ:ATRS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is a 200 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $40.00 million which beat the analyst consensus estimate of $35.67 million by 12.15 percent. This is a 16.61 percent increase over sales of $34.31 million the same period last year.